Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marie-Catherine Romey is active.

Publication


Featured researches published by Marie-Catherine Romey.


The New England Journal of Medicine | 1995

Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens

Miguel Chillón; Teresa Casals; Bernard Mercier; Lluís Bassas; Willy Lissens; Sherman J. Silber; Marie-Catherine Romey; Javier Ruiz-Romero; Claudine Verlingue; Mireille Claustres; Virginia Nunes; Claude Férec; Xavier Estivill

BACKGROUND Congenital bilateral absence of the vas deferens (CBAVD) is a form of male infertility in which mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been identified. The molecular basis of CBAVD is not completely understood. Although patients with cystic fibrosis have mutations in both copies of the CFTR gene, most patients with CBAVD have mutations in only one copy of the gene. METHODS To investigate CBAVD at the molecular level, we have characterized the mutations in the CFTR gene in 102 patients with this condition. None had clinical manifestations of cystic fibrosis. We also analyzed a DNA variant (the 5T allele) in a noncoding region of CFTR that causes reduced levels of the normal CFTR protein. Parents of patients with cystic fibrosis, patients with types of infertility other than CBAVD, and normal subjects were studied as controls. RESULTS Nineteen of the 102 patients with CBAVD had mutations in both copies of the CFTR gene, and none of them had the 5T allele. Fifty-four patients had a mutation in one copy of CFTR, and 34 of them (63 percent) had the 5T allele in the other CFTR gene. In 29 patients no CFTR mutations were found, but 7 of them (24 percent) had the 5T allele. In contrast, the frequency of this allele in the general population was about 5 percent. CONCLUSIONS Most patients with CBAVD have mutations in the CFTR gene. The combination of the 5T allele in one copy of the CFTR gene with a cystic fibrosis mutation in the other copy is the most common cause of CBAVD: The 5T allele mutation has a wide range of clinical presentations, occurring in patients with CBAVD or moderate forms of cystic fibrosis and in fertile men.


Environmental Health Perspectives | 2004

Renal Toxicogenomic Response to Chronic Uranyl Nitrate Insult in Mice

Magali Taulan; F. Paquet; Christophe Maubert; Olivia Delissen; Jacques Demaille; Marie-Catherine Romey

Although the nephrotoxicity of uranium has been established through numerous animal studies, relatively little is known about the effects of long-term environmental uranium exposure. Using a combination of conventional biochemical studies and serial analysis of gene expression (SAGE), we examined the renal responses to uranyl nitrate (UN) chronic exposure. Renal uranium levels were significantly increased 4 months after ingestion of uranium in drinking water. Creatinine levels in serum were slightly but significantly increased compared with those in controls. Although no further significant differences in other parameters were noted, substantial molecular changes were observed in toxicogenomic profiles. UN induced dramatic alterations in expression levels of more than 200 genes, mainly up-regulated, including oxidative-response–related genes, genes encoding for cellular metabolism, ribosomal proteins, signal transduction, and solute transporters. Seven differentially expressed transcripts were confirmed by real-time quantitative polymerase chain reaction. In addition, significantly increased peroxide levels support the implication of oxidative stress in UN toxicant response. This report highlights the potential of SAGE for the discovery of novel toxicant-induced gene expression alterations. Here, we present, for the first time, a comprehensive view of renal molecular events after uranium long-term exposure.


BMC Genomics | 2006

Comprehensive analysis of the renal transcriptional response to acute uranyl nitrate exposure

Magali Taulan; F. Paquet; Àngel Argilés; Jacques Demaille; Marie-Catherine Romey

BackgroundChemical and radiological toxicities related to uranium acute exposure have been widely studied in nuclear fuel workers and military personnel. It is well known that uranyl nitrate induces acute renal failure (ARF). However, the mechanisms of this metal-induced injury are not well defined at the molecular level.ResultsRenal function and histology were assessed in mice receiving uranyl nitrate (UN(+)) and controls (UN(-)). To identify the genomic response to uranium exposure, serial analysis gene expression (SAGE) of the kidney was performed in both groups. Over 43,000 mRNA SAGE tags were sequenced. A selection of the differentially expressed transcripts was confirmed by real-time quantitative PCR and Western blotting. UN(+) animals developed renal failure and displayed the characteristic histological lesions of UN nephropathy. Of the >14,500 unique tags identified in both libraries, 224 had a modified expression level; they are known to participate in inflammation, ion transport, signal transduction, oxidative stress, apoptosis, metabolism, and catabolism. Several genes that were identified had not previously been evaluated within the context of toxic ARF such as translationally controlled tumor protein, insulin like growth factor binding protein 7 and ribosomal protein S29, all apoptosis related genes.ConclusionWe report a comprehensive description of the UN induced modifications in gene expression levels, including the identification of genes previously unrelated to ARF. The study of these genes and the metabolisms they control should improve our understanding of toxic ARF and enlighten on the molecular targets for potential therapeutic interventions.


Nucleic Acids Research | 2005

Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway

Céline René; Magali Taulan; Florence Iral; Julien Doudement; Aurore L'Honoré; Catherine Gerbon; Jacques Demaille; Mireille Claustres; Marie-Catherine Romey

CFTR expression is tightly controlled by a complex network of ubiquitous and tissue-specific cis-elements and trans-factors. To better understand mechanisms that regulate transcription of CFTR, we examined transcription factors that specifically bind a CFTR CArG-like motif we have previously shown to modulate CFTR expression. Gel mobility shift assays and chromatin immunoprecipitation analyses demonstrated the CFTR CArG-like motif binds serum response factor both in vitro and in vivo. Transient co-transfections with various SRF expression vector, including dominant-negative forms and small interfering RNA, demonstrated that SRF significantly increases CFTR transcriptional activity in bronchial epithelial cells. Mutagenesis studies suggested that in addition to SRF other co-factors, such as Yin Yang 1 (YY1) previously shown to bind the CFTR promoter, are potentially involved in the CFTR regulation. Here, we show that functional interplay between SRF and YY1 might provide interesting perspectives to further characterize the underlying molecular mechanism of the basal CFTR transcriptional activity. Furthermore, the identification of multiple CArG binding sites in highly conserved CFTR untranslated regions, which form specific SRF complexes, provides direct evidence for a considerable role of SRF in the CFTR transcriptional regulation into specialized epithelial lung cells.


Human Genetics | 1996

Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction technique and the protein truncation test

Marie-Catherine Romey; Sylvie Tuffery; Marie Desgeorges; Thierry Bienvenu; Jacques Demaille; Mireille Claustres

Abstract mRNA transcripts of the cystic fibrosis transmembrane conductance regulator (CFTR) gene were analyzed from lymphocytes of two cystic fibrosis compound heterozygotes (394delTT/3195del6 and 1215delG/ 2423delG), of five related carriers heterozygous for one of these mutations, and of five normal individuals. After reverse transcription of total RNA and amplification by the polymerase chain reaction, fragments were investigated by sequencing and by the protein truncation test (PTT). The three frameshift mutants were correctly detected by PTT, as they introduced a premature termination codon resulting in shortened protein products. The PTT approach thus provides a simple and reliable alternative method for detecting frameshift, nonsense, or splice site mutations, and for ascertaining their putative effect on the reading frame of the mRNA. In addition, we have identified 6 alternatively spliced forms of CFTR mRNA, two of which (transcripts lacking 4+5 or 17B) have not been described previously.


American Journal of Medical Genetics | 1995

Heterotaxia syndrome and autosomal dominant inheritance.

Sandrine Alonso; Mary Ella Pierpont; Wolfgang Radtke; Jose E. Martinez; Su‐Chiung Chen; James W. Grant; Ingo Dähnert; Sylvie Taviaux; Marie-Catherine Romey; Jacques Demaille; Patrice Bouvagnet


Journal of Biological Chemistry | 2000

A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression.

Marie-Catherine Romey; Nathalie Pallares-Ruiz; Alain Mangé; Clément Mettling; Régis Peytavi; Jacques Demaille; Mireille Claustres


Journal of Medical Genetics | 1999

First putative sequence alterations in the minimal CFTR promoter region

Marie-Catherine Romey; Caroline Guittard; Soukeyna Carles; Jacques Demaille; Mireille Claustres; Michele Ramsay


Human Genetics | 1999

Complex allele [-102T>A+S549R(T>G)] is associated with milder forms of cystic fibrosis than allele S549R(T>G) alone

Marie-Catherine Romey; Caroline Guittard; J.-P. Chazalette; P. Frossard; K.P. Dawson; Michael A. Patton; T. Casals; T. Bazarbachi; E. Girodon; G. Rault; D. Bozon; F. Seguret; Jacques Demaille; Mireille Claustres


Human Molecular Genetics | 1994

A novel splice site mutation in the first exon of the cystic fibrosis transmembrane regulator (CFTR) gene identified in a CBAVD patient

Jean-Francois Culard; Marie Desgeorges; Marie-Catherine Romey; Perrine Malzac; Jacques Demaille; Mireille Claustres

Collaboration


Dive into the Marie-Catherine Romey's collaboration.

Top Co-Authors

Avatar

Jacques Demaille

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Magali Taulan

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar

Caroline Guittard

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Marie Desgeorges

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar

F. Paquet

Institut de radioprotection et de sûreté nucléaire

View shared research outputs
Top Co-Authors

Avatar

Alain Mangé

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Clément Mettling

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Maguelone Laussel

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge